• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻窦炎——克服细菌耐药性。

Sinusitis -- overcoming bacterial resistance.

作者信息

Brook I

机构信息

Georgetown University, 4431 Albemarle Street, Washington, DC 20016, USA.

出版信息

Int J Pediatr Otorhinolaryngol. 2001 Apr 6;58(1):27-36. doi: 10.1016/s0165-5876(00)00457-2.

DOI:10.1016/s0165-5876(00)00457-2
PMID:11249977
Abstract

Sinusitis is a major cause of illness in the USA, and represents a substantial economic burden. Treatment of this condition usually involves antibiotics and, where there is a strong suspicion of bacterial etiology, has a high rate of success. Accurate diagnosis depends upon clinical assessment, but only four specific symptoms have been shown to be independent predictors of sinusitis. Other diagnostic approaches such as analysis of a microbiological sample must be considered in cases failing initial treatment. The main factors in choosing antibiotic therapy are the likely infecting pathogens, bacterial antibiotic resistance and antibiotics' pharmacological profiles. Accurate diagnosis and careful consideration when choosing therapy for sinusitis will optimise the chances of achieving an early cure.

摘要

鼻窦炎是美国疾病的主要成因之一,且带来了巨大的经济负担。这种病症的治疗通常涉及使用抗生素,并且在高度怀疑为细菌病因的情况下,治疗成功率较高。准确的诊断依赖于临床评估,但只有四种特定症状被证明是鼻窦炎的独立预测指标。对于初始治疗失败的病例,必须考虑其他诊断方法,如微生物样本分析。选择抗生素治疗的主要因素包括可能感染的病原体、细菌对抗生素的耐药性以及抗生素的药理学特性。准确诊断并在为鼻窦炎选择治疗方法时仔细考量,将优化实现早期治愈的几率。

相似文献

1
Sinusitis -- overcoming bacterial resistance.鼻窦炎——克服细菌耐药性。
Int J Pediatr Otorhinolaryngol. 2001 Apr 6;58(1):27-36. doi: 10.1016/s0165-5876(00)00457-2.
2
Treatment modalities for bacterial rhinosinusitis.细菌性鼻-鼻窦炎的治疗方法。
Expert Opin Pharmacother. 2010 Apr;11(5):755-69. doi: 10.1517/14656561003598901.
3
Issues in the management of bacterial sinusitis.细菌性鼻窦炎的管理问题
Otolaryngol Head Neck Surg. 2002 Dec;127(6 Suppl):S3-9. doi: 10.1067/mhn.2002.130030.
4
Antimicrobial guidelines for the treatment of acute bacterial rhinosinusitis in immunocompetent children.免疫功能正常儿童急性细菌性鼻窦炎治疗的抗菌指南。
Int J Pediatr Otorhinolaryngol. 2002 Mar 15;63(1):1-13. doi: 10.1016/s0165-5876(01)00631-0.
5
Antibiotic resistance: an emergency we can't ignore.抗生素耐药性:一个我们不能忽视的紧急情况。
Iowa Med. 1995 Mar;85(3):127-8.
6
What role for antibiotics in otitis media and sinusitis?抗生素在中耳炎和鼻窦炎中起什么作用?
Postgrad Med. 1998 Sep;104(3):93-9, 103-4. doi: 10.3810/pgm.1998.09.576.
7
A focus on acute sinusitis in adults: changes in disease management.聚焦成人急性鼻窦炎:疾病管理的变化
Am J Med. 1999 May 3;106(5A):38S-47S; discussion 48S-52S. doi: 10.1016/s0002-9343(98)00352-0.
8
Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis.一线抗生素与二线抗生素治疗急性单纯性鼻窦炎的效果比较
JAMA. 2001 Oct 17;286(15):1849-56. doi: 10.1001/jama.286.15.1849.
9
[Sinusitis is common in small children].鼻窦炎在幼儿中很常见。
Ugeskr Laeger. 2010 Nov 29;172(48):3320-5.
10
[Initial antibiotic therapy in acute otitis media and acute sinusitis in children].
Vestn Otorinolaringol. 2005(3):62-3.

引用本文的文献

1
[Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].[鼻窦炎指南——完整版:德国耳鼻咽喉头颈外科学会S2指南]
HNO. 2012 Feb;60(2):141-62. doi: 10.1007/s00106-011-2396-7.
2
[Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery].[德国耳鼻咽喉头颈外科学会鼻窦炎指南]
HNO. 2007 Oct;55(10):758-60, 762-4, 766-77. doi: 10.1007/s00106-007-1589-6.
3
Induction of CXC chemokines in A549 airway epithelial cells by trypsin and staphylococcal proteases - a possible route for neutrophilic inflammation in chronic rhinosinusitis.
胰蛋白酶和葡萄球菌蛋白酶诱导A549气道上皮细胞中CXC趋化因子——慢性鼻窦炎中性粒细胞炎症的一种可能途径
Clin Exp Immunol. 2006 Jun;144(3):534-42. doi: 10.1111/j.1365-2249.2006.03089.x.